Clearance | Acquisition in non-carriers | Acquisition in carriers | |||||
---|---|---|---|---|---|---|---|
Target serotype | Exposure1 | Events | Person-time2 | Events | Person-time3 | Events | Person-time4 |
19F | Yes | 19 | 58 | 17 | 96 | 5 | 85 |
No | 2 | 2 | 3 | 19 | 0 | 20 | |
23F | Yes | 10 | 23 | 10 | 47 | 2 | 54 |
No | 1 | 3 | 2 | 68 | 1 | 85 | |
6B | Yes | 2 | 13 | 5 | 44 | 5 | 61 |
No | 3 | 7 | 2 | 71 | 3 | 84 | |
14 | Yes | 2 | 10 | 3 | 17 | 6 | 27 |
No | 0 | 0 | 2 | 98 | 4 | 128 | |
10A | Yes | 2 | 11 | 1 | 27 | 1 | 44 |
No | 2 | 2 | 4 | 88 | 5 | 108 | |
19A | Yes | 3 | 7 | 1 | 33 | 0 | 37 |
No | 2 | 4 | 2 | 82 | 2 | 117 | |
NT | Yes | 1 | 5 | 1 | 44 | 3 | 52 |
No | 1 | 6 | 1 | 71 | 3 | 102 | |
16F | Yes | 0 | 0 | 0 | 18 | 0 | 21 |
No | 1 | 2 | 2 | 97 | 3 | 142 | |
18F | Yes | 1 | 1 | 1 | 4 | 0 | 7 |
No | 0 | 0 | 1 | 111 | 2 | 157 | |
11A | Yes | 0 | 0 | 0 | 13 | 1 | 25 |
No | 2 | 3 | 0 | 102 | 0 | 137 | |
23B | Yes | 0 | 0 | 0 | 6 | 0 | 4 |
No | 1 | 1 | 1 | 109 | 0 | 160 | |
9V | Yes | 0 | 2 | 0 | 21 | 1 | 34 |
No | 0 | 4 | 1 | 94 | 0 | 125 | |
15A | Yes | 0 | 0 | 0 | 4 | 0 | 7 |
No | 0 | 1 | 1 | 111 | 0 | 157 | |
8 | Yes | 0 | 0 | 0 | 0 | 0 | 0 |
No | 0 | 0 | 0 | 115 | 1 | 165 | |
Total: | Yes | 40 | 130 | 39 | 374 | 24 | 458 |
No | 15 | 35 | 22 | 1236 | 24 | 1687 | |
55 | 165 | 78 | 1610 | 48 | 2145 |